Aldara and Viral upper respiratory tract infection - a phase IV clinical study of FDA data

Summary:

Viral upper respiratory tract infection is reported only by a few people who take Aldara.

The phase IV clinical study analyzes which people take Aldara and have Viral upper respiratory tract infection. It is created by eHealthMe based on reports of 2,419 people who have side effects while taking Aldara from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

2,419 people reported to have side effects when taking Aldara.
Among them, 4 people (0.17%) have Viral upper respiratory tract infection.

What is Aldara?

Aldara has active ingredients of imiquimod. It is often used in genital warts. eHealthMe is studying from 2,495 Aldara users for its effectiveness, alternative drugs and more.

What is Viral upper respiratory tract infection?

Viral upper respiratory tract infection is found to be associated with 1,134 drugs and 514 conditions by eHealthMe.

Number of Aldara and Viral upper respiratory tract infection reports submitted per year:

Could Aldara cause Viral upper respiratory tract infection?

Gender of people who have Viral upper respiratory tract infection when taking Aldara *:

female: 100 %
male: 0.0 %

Age of people who have Viral upper respiratory tract infection when taking Aldara *:

Common drugs people take besides Aldara *:

Common side effects people have besides Viral upper respiratory tract infection *:

Otitis (ear infection): 4 people, 100.00%
Pyelocaliectasis: 4 people, 100.00%
Hepatomegaly (abnormal enlargement of the liver): 4 people, 100.00%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 4 people, 100.00%
Hair Loss: 4 people, 100.00%
Hodgkin's Lymphoma (cancer originating from white blood cells): 4 people, 100.00%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 4 people, 100.00%
Haematochezia (passage of stools containing blood): 4 people, 100.00%
Keloids (overgrown scars left from skin injuries): 4 people, 100.00%
Laryngocele (a congenital anomalous air sac communicating with the cavity of the larynx): 4 people, 100.00%

Common conditions people have *:

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 100.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aldara and have Viral upper respiratory tract infection?

Check whether Viral upper respiratory tract infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Viral upper respiratory tract infection and when was it recovered:

Viral upper respiratory tract infection in Aldara

Expand to all the drugs that have ingredients of imiquimod:

Viral upper respiratory tract infection and drugs with ingredients of imiquimod (4 reports)

Alternative drugs to, pros and cons of Aldara:

Aldara (2,495 reports)

Common Aldara side effects:

Pain: 387 reports
Itching: 217 reports
Fatigue (feeling of tiredness): 164 reports
Rashes (redness): 130 reports

Browse all side effects of Aldara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Viral upper respiratory tract infection treatments and more:

Viral upper respiratory tract infection (7,323 reports)

COVID vaccines that are related to Viral upper respiratory tract infection:

Common drugs associated with Viral upper respiratory tract infection:

All the drugs that are associated with Viral upper respiratory tract infection:

Viral upper respiratory tract infection (1,134 drugs)

Common conditions associated with Viral upper respiratory tract infection:

Rheumatoid arthritis: 1,023 reports
Asthma: 367 reports
Multiple sclerosis: 268 reports
Multiple myeloma: 243 reports
Psoriasis: 236 reports
High blood pressure: 185 reports
Primary pulmonary hypertension: 163 reports
Osteoporosis: 155 reports
Pain: 149 reports

All the conditions that are associated with Viral upper respiratory tract infection:

Viral upper respiratory tract infection (514 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on imiquimod (the active ingredients of Aldara) and Aldara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.